Alternatives to Cradle Bio

SciSpace BioMed Agent runs multi-omics, variant prioritization, and drug repurposing analysis from plain-language biomedical prompts.

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Automated cloud lab for protein validation — binding, expression and thermostability assays with data back in as little as 3 days

Nanograb designs peptide-LNP targeting systems with biophysics-informed AI so genetic medicines reach a chosen cell type instead of the

Physics-based molecular simulation and AI for drug discovery and materials design.

Cloud R&D platform combining ELN, LIMS, automation, and agent-driven Science Foundries for biotech.

AI-native drug discovery company pairing 20+ petabytes of cellular data with human genetics to find causal disease targets

BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.

Owkin pairs K Pro, an autonomous AI scientist, with 25 million patients' data across 840 hospitals and wet lab validation for drug R&D

Enterprise scientific intelligence platform whose Luma Agent plans, runs and documents R&D data analysis under human approval

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

NovaFlow is an AI data analyst for biology labs that turns raw sequencing output into cited, publication-ready results.

Delineate assembles clinical pharmacology evidence into MBMA databases and models for dose optimization and go/no-go decisions.

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

Cellbyte gives pharma Pricing & Market Access teams source-linked HTA and pricing answers in minutes, not weeks.

Oncology real-world evidence built from point-of-care data, with AI-driven insights across a global database of six million+ patients.

Iktos pairs generative AI for small-molecule design with AI retrosynthesis and an autonomous robotic DMTA lab.

Cellino's AI-guided optical bioprocessing platform brings patient-specific cell therapy manufacturing to the hospital.

AI-native pharma company using autonomous agents to find new uses for existing drugs and predict patient drug response

HealthKey uses AI patient identification to scan your EHR daily and surface trial-eligible patients for clinical research.

Haplotype Labs builds SaaS and community tooling for population genetics, aiming to cut sequencing costs 50–90% and speed polygenic risk modeling.

Frekils is AI agents for real-world evidence studies — cohorts, SAPs and publication-ready statistics on your own clinical data.

AI drug discovery driven by a wet-and-dry lab-in-the-loop that runs millions of weekly cell experiments.

AI-CRISPR target discovery platform pairing AlgenCRISPR gene modulation with the AlgenBrain foundation model for causal immunology and

Clinician-centered clinical trial matching that notifies your patients when a local, medically relevant study exists.

Project-based AI biopharma team that delivers decision-grade research, analysis, and computational design in 3–5 days.

AI platform that predicts and optimizes molecular constructs for gene and RNA therapy before synthesis

vBx-1.0 predicts brain activity, therapy response, and side effects from a routine blood draw, for precision neurology trials.

AI scientific diligence software for pharma BD, biotech and life science investors evaluating in-licensing, M&A and investment decisions

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.